Investigational Site Number :1240006

Surrey, British Columbia V3T 2V6

0 studies enrolling now · 2 studies all time

What they study most

Neurodermatitis, Type 1 Diabetes Mellitus

Studies at this site

• Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule — Running, not enrolling
• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed